SIO and SB should be an offsetting influence to Mercer (to an extent) as they are large holders of AVRO (not sure if SB still hold as selling down heads).
Lets see, bring on FDA trial submission.
Cheers,
Nathan
Wayne interview with Fortem Wealth 25/5/21 11am, page-40
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.50 |
Change
-0.550(2.61%) |
Mkt cap ! $393.8M | |||
| Open | High | Low | Value | Volume |
| $21.05 | $21.05 | $20.00 | $268.0K | 13.12K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 492 | $20.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.50 | 1046 | 2 |
View Market Depth
| Last trade - 16.10pm 13/05/2024 (20 minute delay) ? |
| AVR (ASX) Chart |